TFDP1: Transcription Factor Dp-1 – A Key Regulator of Cell Cycle and E2F-Mediated Transcription

Comprehensive genomic, functional, and clinical overview of TFDP1, a dimerization partner of E2F transcription factors involved in cell proliferation and cancer.

Gene Information Card

Symbol TFDP1
Full Name Transcription factor Dp-1
Gene Type Protein coding
Chromosomal Location 13q34
NCBI Gene ID 7027 ncbi.nlm.nih.gov/gene/7027
Ensembl ID ENSG00000139687
UniProt ID Q14186
OMIM ID 189902
HGNC ID 11749
Aliases DP1, Dp-1, E2F dimerization partner 1

Description

TFDP1 (Transcription Factor Dp-1) encodes a member of the DP family of transcription factors. The protein forms heterodimers with E2F family members, thereby regulating the expression of genes involved in cell cycle progression, DNA replication, and apoptosis. TFDP1 is essential for the transcriptional activity of E2F complexes and is a key component of the retinoblastoma (RB) tumor suppressor pathway. Alterations in TFDP1 expression or function have been implicated in various cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Retinoblastoma TFDP1 dimerizes with E2F to regulate RB pathway; disruption contributes to tumorigenesis OMIM #180200; PubMed studies
Lung cancer Overexpression of TFDP1 promotes cell proliferation and invasion COSMIC; PubMed
Breast cancer TFDP1 amplification and overexpression linked to poor prognosis COSMIC; PubMed
Colorectal cancer TFDP1 upregulation associated with tumor progression COSMIC; PubMed

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 12.5 High
Lymph node 8.3 Medium
Bone marrow 7.1 Medium
Brain 4.2 Low
Liver 3.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa 15.2 Cervical cancer cell line; high expression
A549 11.7 Lung carcinoma; moderate-high
MCF7 9.4 Breast cancer; moderate
HEK293 6.8 Embryonic kidney; low-moderate
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1A>G (p.Met1?) Missense <0.1% Potential loss of start codon; likely loss-of-function
c.487C>T (p.Arg163Trp) Missense <0.1% Unknown significance; reported in COSMIC
c.632_633insA (p.Gln211fs) Frameshift <0.1% Loss-of-function; truncation
Amplification Copy number gain Variable Gain-of-function; observed in multiple cancers
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations that truncate the protein, impairing dimerization with E2F and transcriptional activation.

Gain of Function (GOF)

Gene amplification or overexpression leading to increased E2F activity and enhanced cell cycle progression.

Dominant Negative (DN)

Missense mutations in the dimerization domain that disrupt E2F binding but retain partial function, potentially interfering with wild-type DP1.

Pathways

Cell Cycle (KEGG hsa04110)
E2F transcription factor network (Reactome R-HSA-8953897)
Retinoblastoma (RB) pathway in cancer (Reactome R-HSA-5628897)

Protein Summary

TFDP1 encodes the 410-amino acid Transcription Factor Dp-1 protein. It contains a conserved DNA-binding/dimerization domain that mediates heterodimerization with E2F transcription factors. The DP1-E2F complex binds to E2F-responsive promoters to regulate genes essential for G1/S transition. Post-translational modifications, including phosphorylation, modulate its activity. TFDP1 is ubiquitously expressed with highest levels in testis and lymphoid tissues. Its dysregulation is linked to multiple cancer types.

Related Products

Product name Cat.No. Species Gene ID
TFDP1 Knockout HEK293 Cell Line EDJ-KQ409 Human 7027 Details Get a Quote
TFDP1 Knockout HCT 116 Cell Line EDJ-KQ18663 Human 7027 Details Get a Quote
TFDP1 Knockout HeLa Cell Line EDJ-KQ18664 Human 7027 Details Get a Quote
TFDP1 Knockout A-549 Cell Line EDJ-KQ63124 Human 7027 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: